

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.69800823 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.69800823 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 5.68979707 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.39526836 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.39526836 |
| 6 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 5.34676452 |
| 7 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.30121890 |
| 8 | cholesterol biosynthetic process (GO:0006695) | 5.11170615 |
| 9 | acetyl-CoA metabolic process (GO:0006084) | 5.06871039 |
| 10 | acyl-CoA biosynthetic process (GO:0071616) | 4.92093766 |
| 11 | thioester biosynthetic process (GO:0035384) | 4.92093766 |
| 12 | behavioral response to nicotine (GO:0035095) | 4.87394428 |
| 13 | low-density lipoprotein particle clearance (GO:0034383) | 4.82054730 |
| 14 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.64923021 |
| 15 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.63518223 |
| 16 | sterol biosynthetic process (GO:0016126) | 4.52359121 |
| 17 | biotin metabolic process (GO:0006768) | 4.48501392 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 4.45505421 |
| 19 | fatty acid elongation (GO:0030497) | 4.42987760 |
| 20 | triglyceride biosynthetic process (GO:0019432) | 4.26702110 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 4.25193888 |
| 22 | L-fucose catabolic process (GO:0042355) | 4.24592042 |
| 23 | fucose catabolic process (GO:0019317) | 4.24592042 |
| 24 | L-fucose metabolic process (GO:0042354) | 4.24592042 |
| 25 | regulation of hippo signaling (GO:0035330) | 4.16788353 |
| 26 | glyoxylate metabolic process (GO:0046487) | 4.09962681 |
| 27 | neutral lipid biosynthetic process (GO:0046460) | 4.09510450 |
| 28 | acylglycerol biosynthetic process (GO:0046463) | 4.09510450 |
| 29 | very long-chain fatty acid metabolic process (GO:0000038) | 4.05276749 |
| 30 | thioester metabolic process (GO:0035383) | 4.00205928 |
| 31 | acyl-CoA metabolic process (GO:0006637) | 4.00205928 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.98307829 |
| 33 | regulation of cholesterol homeostasis (GO:2000188) | 3.94447816 |
| 34 | coenzyme A metabolic process (GO:0015936) | 3.90570063 |
| 35 | cysteine metabolic process (GO:0006534) | 3.89809340 |
| 36 | plasma lipoprotein particle clearance (GO:0034381) | 3.86402160 |
| 37 | short-chain fatty acid metabolic process (GO:0046459) | 3.78197310 |
| 38 | fatty acid beta-oxidation (GO:0006635) | 3.77565229 |
| 39 | coenzyme catabolic process (GO:0009109) | 3.71967709 |
| 40 | cellular ketone body metabolic process (GO:0046950) | 3.68002998 |
| 41 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.67621801 |
| 42 | primary amino compound metabolic process (GO:1901160) | 3.67353995 |
| 43 | bile acid biosynthetic process (GO:0006699) | 3.66623162 |
| 44 | triglyceride catabolic process (GO:0019433) | 3.66324840 |
| 45 | fatty acid catabolic process (GO:0009062) | 3.63691728 |
| 46 | fatty acid oxidation (GO:0019395) | 3.57810672 |
| 47 | valine metabolic process (GO:0006573) | 3.57412975 |
| 48 | neutral lipid catabolic process (GO:0046461) | 3.55369377 |
| 49 | acylglycerol catabolic process (GO:0046464) | 3.55369377 |
| 50 | tyrosine metabolic process (GO:0006570) | 3.55133619 |
| 51 | triglyceride metabolic process (GO:0006641) | 3.52711403 |
| 52 | lipid oxidation (GO:0034440) | 3.50869208 |
| 53 | acylglycerol homeostasis (GO:0055090) | 3.49249738 |
| 54 | triglyceride homeostasis (GO:0070328) | 3.49249738 |
| 55 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.48219346 |
| 56 | regulation of cholesterol metabolic process (GO:0090181) | 3.45320998 |
| 57 | lysine catabolic process (GO:0006554) | 3.44190285 |
| 58 | lysine metabolic process (GO:0006553) | 3.44190285 |
| 59 | regulation of gene silencing by miRNA (GO:0060964) | 3.43895321 |
| 60 | regulation of gene silencing by RNA (GO:0060966) | 3.43895321 |
| 61 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.43895321 |
| 62 | linoleic acid metabolic process (GO:0043651) | 3.41076449 |
| 63 | serotonin metabolic process (GO:0042428) | 3.40049018 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 3.39403143 |
| 65 | protein carboxylation (GO:0018214) | 3.36054056 |
| 66 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.36054056 |
| 67 | branched-chain amino acid catabolic process (GO:0009083) | 3.34943859 |
| 68 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.34615096 |
| 69 | complement activation, alternative pathway (GO:0006957) | 3.34576452 |
| 70 | aromatic amino acid family metabolic process (GO:0009072) | 3.33072704 |
| 71 | serine family amino acid catabolic process (GO:0009071) | 3.32960823 |
| 72 | indole-containing compound catabolic process (GO:0042436) | 3.32874209 |
| 73 | indolalkylamine catabolic process (GO:0046218) | 3.32874209 |
| 74 | tryptophan catabolic process (GO:0006569) | 3.32874209 |
| 75 | branched-chain amino acid metabolic process (GO:0009081) | 3.32714653 |
| 76 | acylglycerol metabolic process (GO:0006639) | 3.31573953 |
| 77 | regulation of triglyceride catabolic process (GO:0010896) | 3.30773069 |
| 78 | bile acid metabolic process (GO:0008206) | 3.29680612 |
| 79 | neutral lipid metabolic process (GO:0006638) | 3.27890260 |
| 80 | monocarboxylic acid catabolic process (GO:0072329) | 3.26715236 |
| 81 | ketone body metabolic process (GO:1902224) | 3.25828667 |
| 82 | homocysteine metabolic process (GO:0050667) | 3.24791238 |
| 83 | tricarboxylic acid metabolic process (GO:0072350) | 3.24221539 |
| 84 | kynurenine metabolic process (GO:0070189) | 3.23061678 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 3.22731903 |
| 86 | negative regulation of fibrinolysis (GO:0051918) | 3.22022919 |
| 87 | isoprenoid biosynthetic process (GO:0008299) | 3.21757456 |
| 88 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.19073906 |
| 89 | L-serine metabolic process (GO:0006563) | 3.18629829 |
| 90 | tryptophan metabolic process (GO:0006568) | 3.16468477 |
| 91 | pantothenate metabolic process (GO:0015939) | 3.15998400 |
| 92 | alpha-amino acid catabolic process (GO:1901606) | 3.15856898 |
| 93 | regulation of sequestering of triglyceride (GO:0010889) | 3.15810609 |
| 94 | neuronal action potential (GO:0019228) | 3.15198476 |
| 95 | serine family amino acid metabolic process (GO:0009069) | 3.15153117 |
| 96 | NADPH regeneration (GO:0006740) | 3.14344860 |
| 97 | ethanol oxidation (GO:0006069) | 3.14044424 |
| 98 | drug transmembrane transport (GO:0006855) | 3.13903324 |
| 99 | cholesterol metabolic process (GO:0008203) | 3.13852965 |
| 100 | urea cycle (GO:0000050) | 3.12290368 |
| 101 | urea metabolic process (GO:0019627) | 3.12290368 |
| 102 | cellular amino acid catabolic process (GO:0009063) | 3.11689340 |
| 103 | protein K11-linked deubiquitination (GO:0035871) | 3.10738987 |
| 104 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.10720309 |
| 105 | indole-containing compound metabolic process (GO:0042430) | 3.10241147 |
| 106 | amino-acid betaine metabolic process (GO:0006577) | 3.08833808 |
| 107 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.07623943 |
| 108 | detection of light stimulus involved in visual perception (GO:0050908) | 3.07623943 |
| 109 | organic acid catabolic process (GO:0016054) | 3.06565884 |
| 110 | carboxylic acid catabolic process (GO:0046395) | 3.06565884 |
| 111 | positive regulation of lipid catabolic process (GO:0050996) | 3.05200637 |
| 112 | response to lipoprotein particle (GO:0055094) | 3.04533911 |
| 113 | nucleobase catabolic process (GO:0046113) | 3.04463615 |
| 114 | nucleoside bisphosphate metabolic process (GO:0033865) | 3.03692443 |
| 115 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 3.03692443 |
| 116 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 3.03692443 |
| 117 | NADP metabolic process (GO:0006739) | 3.02314429 |
| 118 | reflex (GO:0060004) | 3.00476797 |
| 119 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.97450962 |
| 120 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.93764267 |
| 121 | response to pheromone (GO:0019236) | 2.93033814 |
| 122 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.92431748 |
| 123 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.92431748 |
| 124 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.92431748 |
| 125 | gamma-aminobutyric acid transport (GO:0015812) | 2.88899080 |
| 126 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.83829883 |
| 127 | nephron tubule morphogenesis (GO:0072078) | 2.77228042 |
| 128 | nephron epithelium morphogenesis (GO:0072088) | 2.77228042 |
| 129 | endosome to melanosome transport (GO:0035646) | 2.74643807 |
| 130 | endosome to pigment granule transport (GO:0043485) | 2.74643807 |
| 131 | protein import into peroxisome matrix (GO:0016558) | 2.74069841 |
| 132 | behavioral response to ethanol (GO:0048149) | 2.68305999 |
| 133 | regulation of action potential (GO:0098900) | 2.66251151 |
| 134 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.65692767 |
| 135 | replicative senescence (GO:0090399) | 2.65100024 |
| 136 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.63954358 |
| 137 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.63304847 |
| 138 | regulation of mesoderm development (GO:2000380) | 2.62293673 |
| 139 | kidney morphogenesis (GO:0060993) | 2.61911164 |
| 140 | retinal cone cell development (GO:0046549) | 2.57733066 |
| 141 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.56595069 |
| 142 | positive regulation of glycolytic process (GO:0045821) | 2.51708293 |
| 143 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.51620883 |
| 144 | spinal cord motor neuron differentiation (GO:0021522) | 2.50212152 |
| 145 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.49981038 |
| 146 | regulation of hexokinase activity (GO:1903299) | 2.49588077 |
| 147 | regulation of glucokinase activity (GO:0033131) | 2.49588077 |
| 148 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.49174924 |
| 149 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.49174924 |
| 150 | peristalsis (GO:0030432) | 2.48186726 |
| 151 | fucosylation (GO:0036065) | 2.47987685 |
| 152 | membrane depolarization during action potential (GO:0086010) | 2.47557249 |
| 153 | negative regulation of telomere maintenance (GO:0032205) | 2.46916352 |
| 154 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.46200671 |
| 155 | thyroid hormone metabolic process (GO:0042403) | 2.45714232 |
| 156 | glycerophospholipid catabolic process (GO:0046475) | 2.44030895 |
| 157 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.43904623 |
| 158 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.43645654 |
| 159 | protein K48-linked deubiquitination (GO:0071108) | 2.42380577 |
| 160 | proline transport (GO:0015824) | 2.40880094 |
| 161 | action potential (GO:0001508) | 2.40285091 |
| 162 | aspartate family amino acid catabolic process (GO:0009068) | 2.36307460 |
| 163 | rRNA catabolic process (GO:0016075) | 2.36197093 |
| 164 | cAMP catabolic process (GO:0006198) | 2.36173116 |
| 165 | negative regulation of sodium ion transport (GO:0010766) | 2.35599595 |
| 166 | sulfation (GO:0051923) | 2.33141199 |
| 167 | positive regulation of fatty acid transport (GO:2000193) | 2.32551081 |
| 168 | NAD biosynthetic process (GO:0009435) | 2.31259095 |
| 169 | fatty acid transmembrane transport (GO:1902001) | 2.30249534 |
| 170 | DNA methylation involved in gamete generation (GO:0043046) | 2.30052978 |
| 171 | urinary tract smooth muscle contraction (GO:0014848) | 2.28979485 |
| 172 | signal peptide processing (GO:0006465) | 2.28961360 |
| 173 | cornea development in camera-type eye (GO:0061303) | 2.28955185 |
| 174 | reciprocal DNA recombination (GO:0035825) | 2.28471278 |
| 175 | reciprocal meiotic recombination (GO:0007131) | 2.28471278 |
| 176 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.28179451 |
| 177 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.27593216 |
| 178 | snRNA transcription (GO:0009301) | 2.25240732 |
| 179 | photoreceptor cell maintenance (GO:0045494) | 2.23539468 |
| 180 | positive regulation of fatty acid oxidation (GO:0046321) | 2.23245241 |
| 181 | cellular biogenic amine catabolic process (GO:0042402) | 2.22862166 |
| 182 | amine catabolic process (GO:0009310) | 2.22862166 |
| 183 | positive regulation of action potential (GO:0045760) | 2.22204737 |
| 184 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.22105181 |
| 185 | piRNA metabolic process (GO:0034587) | 2.21825396 |
| 186 | positive regulation of prostaglandin secretion (GO:0032308) | 2.21583290 |
| 187 | multicellular organismal movement (GO:0050879) | 2.21412249 |
| 188 | musculoskeletal movement (GO:0050881) | 2.21412249 |
| 189 | potassium ion transmembrane transport (GO:0071805) | 2.20653177 |
| 190 | cellular potassium ion transport (GO:0071804) | 2.20653177 |
| 191 | transmission of nerve impulse (GO:0019226) | 2.20518250 |
| 192 | alanine transport (GO:0032328) | 2.20450093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.94034189 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.83296920 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.94554173 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.05214760 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.72882881 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.87437907 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.67418898 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.47362124 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.45571864 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.37430708 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.34229473 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.25252019 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.80377688 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.69575450 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.61470742 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.55725400 |
| 17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.54379513 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.48696324 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.44608947 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.39808362 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.34469051 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.24497246 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.22144762 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.08558456 |
| 25 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.03881435 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03163570 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.97735669 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.96818901 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.95825144 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.90116909 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.85790424 |
| 32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.84589389 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82648566 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78635858 |
| 35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.73905865 |
| 36 | STAT3_23295773_ChIP-Seq_U87_Human | 1.69699092 |
| 37 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.66899016 |
| 38 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63370087 |
| 39 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.59882470 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59636982 |
| 41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59108921 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.56972752 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.55844446 |
| 44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55640534 |
| 45 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.52350510 |
| 46 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.51974930 |
| 47 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.51856732 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50391389 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50056010 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.49329801 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49103784 |
| 52 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.48519214 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47461422 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.46594431 |
| 55 | TCF4_23295773_ChIP-Seq_U87_Human | 1.46131894 |
| 56 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.45744767 |
| 57 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.45292742 |
| 58 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.45135854 |
| 59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42570186 |
| 60 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39330079 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39302895 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.39067063 |
| 63 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.39057118 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37419360 |
| 65 | EWS_26573619_Chip-Seq_HEK293_Human | 1.36571822 |
| 66 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35969601 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.34813262 |
| 68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.32676324 |
| 69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32646378 |
| 70 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.32486017 |
| 71 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.32486017 |
| 72 | TP53_16413492_ChIP-PET_HCT116_Human | 1.30828606 |
| 73 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.30133365 |
| 74 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.29161105 |
| 75 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29046244 |
| 76 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28463529 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28170588 |
| 78 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.26917791 |
| 79 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.26099575 |
| 80 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26099575 |
| 81 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.25873115 |
| 82 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.25633524 |
| 83 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25503066 |
| 84 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25295204 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.24499178 |
| 86 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23606671 |
| 87 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22511467 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20954472 |
| 89 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20652150 |
| 90 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17982052 |
| 91 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17593960 |
| 92 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.17587031 |
| 93 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.17587031 |
| 94 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.17441936 |
| 95 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.17294512 |
| 96 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.15844196 |
| 97 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.15745451 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14973421 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14832245 |
| 100 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14571334 |
| 101 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14486121 |
| 102 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.13951428 |
| 103 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13286639 |
| 104 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.12952683 |
| 105 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.11665489 |
| 106 | ERA_21632823_ChIP-Seq_H3396_Human | 1.11129682 |
| 107 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.09821933 |
| 108 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.09616313 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08964804 |
| 110 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.07342199 |
| 111 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.06685583 |
| 112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06370266 |
| 113 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06346793 |
| 114 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05739667 |
| 115 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.05659821 |
| 116 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.05641533 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05469817 |
| 118 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05268428 |
| 119 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03801098 |
| 120 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03529061 |
| 121 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03270883 |
| 122 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02305832 |
| 123 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.01574413 |
| 124 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.00375994 |
| 125 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00309198 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00128941 |
| 127 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99940609 |
| 128 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99308605 |
| 129 | AR_19668381_ChIP-Seq_PC3_Human | 0.99198722 |
| 130 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99120162 |
| 131 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98220596 |
| 132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98216980 |
| 133 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97944313 |
| 134 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97623958 |
| 135 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97584418 |
| 136 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96864731 |
| 137 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.95955057 |
| 138 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.95908305 |
| 139 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.95010579 |
| 140 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.93121196 |
| 141 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92342679 |
| 142 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91689110 |
| 143 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.91418263 |
| 144 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89813341 |
| 145 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88881164 |
| 146 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88490845 |
| 147 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.87382058 |
| 148 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86190958 |
| 149 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86085387 |
| 150 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86085387 |
| 151 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85032259 |
| 152 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.78264066 |
| 153 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77727429 |
| 154 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.76285930 |
| 155 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76195087 |
| 156 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.76030447 |
| 157 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.75709507 |
| 158 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.74235255 |
| 159 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.74140338 |
| 160 | ATF3_27146783_Chip-Seq_COLON_Human | 0.73889958 |
| 161 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73406782 |
| 162 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72930364 |
| 163 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.71791569 |
| 164 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71552499 |
| 165 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71539538 |
| 166 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71042074 |
| 167 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.70871658 |
| 168 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.70652103 |
| 169 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70137035 |
| 170 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.70135236 |
| 171 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.69968973 |
| 172 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.69832851 |
| 173 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.67262339 |
| 174 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66959954 |
| 175 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.65940089 |
| 176 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.65593258 |
| 177 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.64971002 |
| 178 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.64137995 |
| 179 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.62870216 |
| 180 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62289622 |
| 181 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.61432615 |
| 182 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.61430193 |
| 183 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.61265334 |
| 184 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.60902525 |
| 185 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.60875049 |
| 186 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60610258 |
| 187 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.59964013 |
| 188 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59597215 |
| 189 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.59427152 |
| 190 | P68_20966046_ChIP-Seq_HELA_Human | 0.59316954 |
| 191 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.59064786 |
| 192 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.58018191 |
| 193 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.58007511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.30177741 |
| 2 | MP0005360_urolithiasis | 5.43420023 |
| 3 | MP0005365_abnormal_bile_salt | 4.35556002 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.69444725 |
| 5 | MP0009840_abnormal_foam_cell | 3.23481067 |
| 6 | MP0005670_abnormal_white_adipose | 3.18363120 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.15022310 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.11891656 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.10860913 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.86819094 |
| 11 | MP0003195_calcinosis | 2.83479280 |
| 12 | MP0005332_abnormal_amino_acid | 2.65917800 |
| 13 | MP0002118_abnormal_lipid_homeostasis | 2.52632862 |
| 14 | MP0009046_muscle_twitch | 2.50276252 |
| 15 | MP0003252_abnormal_bile_duct | 2.50269268 |
| 16 | MP0003329_amyloid_beta_deposits | 2.50227430 |
| 17 | MP0005083_abnormal_biliary_tract | 2.47436881 |
| 18 | MP0005645_abnormal_hypothalamus_physiol | 2.19614640 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.16810693 |
| 20 | MP0005666_abnormal_adipose_tissue | 2.15717435 |
| 21 | MP0000013_abnormal_adipose_tissue | 2.14101112 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 2.12030298 |
| 23 | MP0008872_abnormal_physiological_respon | 2.11586705 |
| 24 | MP0009745_abnormal_behavioral_response | 2.06955415 |
| 25 | MP0008877_abnormal_DNA_methylation | 2.05424750 |
| 26 | MP0000383_abnormal_hair_follicle | 2.02876600 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.01300578 |
| 28 | MP0000427_abnormal_hair_cycle | 1.98637921 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.97482203 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.96977546 |
| 31 | MP0000609_abnormal_liver_physiology | 1.91937005 |
| 32 | MP0002736_abnormal_nociception_after | 1.84403112 |
| 33 | MP0004130_abnormal_muscle_cell | 1.83706085 |
| 34 | MP0000604_amyloidosis | 1.82053188 |
| 35 | MP0001661_extended_life_span | 1.81211785 |
| 36 | MP0005275_abnormal_skin_tensile | 1.73301218 |
| 37 | MP0005375_adipose_tissue_phenotype | 1.73278032 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.72637180 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.71740674 |
| 40 | MP0001666_abnormal_nutrient_absorption | 1.69159551 |
| 41 | MP0002064_seizures | 1.68805896 |
| 42 | MP0003136_yellow_coat_color | 1.67585876 |
| 43 | MP0002272_abnormal_nervous_system | 1.67204422 |
| 44 | MP0000569_abnormal_digit_pigmentation | 1.65405289 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.63588532 |
| 46 | MP0005377_hearing/vestibular/ear_phenot | 1.60889166 |
| 47 | MP0003878_abnormal_ear_physiology | 1.60889166 |
| 48 | MP0003787_abnormal_imprinting | 1.60685407 |
| 49 | MP0002971_abnormal_brown_adipose | 1.59033702 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.58576190 |
| 51 | MP0001485_abnormal_pinna_reflex | 1.57870088 |
| 52 | MP0003646_muscle_fatigue | 1.56528415 |
| 53 | MP0002638_abnormal_pupillary_reflex | 1.55904096 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.55742463 |
| 55 | MP0002572_abnormal_emotion/affect_behav | 1.52051719 |
| 56 | MP0006072_abnormal_retinal_apoptosis | 1.52012101 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 1.48564871 |
| 58 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46192645 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.44039520 |
| 60 | MP0003690_abnormal_glial_cell | 1.43391559 |
| 61 | MP0005386_behavior/neurological_phenoty | 1.43092248 |
| 62 | MP0004924_abnormal_behavior | 1.43092248 |
| 63 | MP0000631_abnormal_neuroendocrine_gland | 1.42356796 |
| 64 | MP0003635_abnormal_synaptic_transmissio | 1.42154687 |
| 65 | MP0005334_abnormal_fat_pad | 1.41735017 |
| 66 | MP0001756_abnormal_urination | 1.41544775 |
| 67 | MP0004043_abnormal_pH_regulation | 1.41320056 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.41226972 |
| 69 | MP0004885_abnormal_endolymph | 1.40869316 |
| 70 | MP0002102_abnormal_ear_morphology | 1.40653659 |
| 71 | MP0000003_abnormal_adipose_tissue | 1.40153444 |
| 72 | MP0010678_abnormal_skin_adnexa | 1.40005066 |
| 73 | MP0003890_abnormal_embryonic-extraembry | 1.38557880 |
| 74 | MP0004147_increased_porphyrin_level | 1.38295886 |
| 75 | MP0002557_abnormal_social/conspecific_i | 1.38247152 |
| 76 | MP0000920_abnormal_myelination | 1.36391747 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 1.35674615 |
| 78 | MP0002876_abnormal_thyroid_physiology | 1.34908470 |
| 79 | MP0002734_abnormal_mechanical_nocicepti | 1.32081331 |
| 80 | MP0003186_abnormal_redox_activity | 1.31893487 |
| 81 | MP0002837_dystrophic_cardiac_calcinosis | 1.31786558 |
| 82 | MP0002938_white_spotting | 1.30918979 |
| 83 | MP0006292_abnormal_olfactory_placode | 1.30511676 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 1.30015309 |
| 85 | MP0006276_abnormal_autonomic_nervous | 1.29925671 |
| 86 | MP0001486_abnormal_startle_reflex | 1.29321087 |
| 87 | MP0005451_abnormal_body_composition | 1.29271469 |
| 88 | MP0002063_abnormal_learning/memory/cond | 1.28893332 |
| 89 | MP0004133_heterotaxia | 1.28398248 |
| 90 | MP0002160_abnormal_reproductive_system | 1.27653971 |
| 91 | MP0004142_abnormal_muscle_tone | 1.27644975 |
| 92 | MP0005253_abnormal_eye_physiology | 1.27234600 |
| 93 | MP0002796_impaired_skin_barrier | 1.25868305 |
| 94 | MP0001764_abnormal_homeostasis | 1.24765179 |
| 95 | MP0005535_abnormal_body_temperature | 1.23445991 |
| 96 | MP0001984_abnormal_olfaction | 1.23240800 |
| 97 | MP0010386_abnormal_urinary_bladder | 1.20712090 |
| 98 | MP0002653_abnormal_ependyma_morphology | 1.20274077 |
| 99 | MP0001970_abnormal_pain_threshold | 1.17936803 |
| 100 | MP0002970_abnormal_white_adipose | 1.16253126 |
| 101 | MP0003718_maternal_effect | 1.15568520 |
| 102 | MP0004859_abnormal_synaptic_plasticity | 1.12054996 |
| 103 | MP0003119_abnormal_digestive_system | 1.10702943 |
| 104 | MP0003868_abnormal_feces_composition | 1.10571013 |
| 105 | MP0002067_abnormal_sensory_capabilities | 1.09575506 |
| 106 | MP0003880_abnormal_central_pattern | 1.09492366 |
| 107 | MP0004145_abnormal_muscle_electrophysio | 1.09472683 |
| 108 | MP0002693_abnormal_pancreas_physiology | 1.08512134 |
| 109 | MP0005379_endocrine/exocrine_gland_phen | 1.07178956 |
| 110 | MP0005389_reproductive_system_phenotype | 1.06958945 |
| 111 | MP0003959_abnormal_lean_body | 1.06037688 |
| 112 | MP0003283_abnormal_digestive_organ | 1.05933195 |
| 113 | MP0004742_abnormal_vestibular_system | 1.04952226 |
| 114 | MP0001529_abnormal_vocalization | 1.04483439 |
| 115 | MP0002234_abnormal_pharynx_morphology | 1.03913872 |
| 116 | MP0005448_abnormal_energy_balance | 1.03791494 |
| 117 | MP0001919_abnormal_reproductive_system | 1.02481951 |
| 118 | MP0005636_abnormal_mineral_homeostasis | 1.02142084 |
| 119 | MP0002184_abnormal_innervation | 1.01870541 |
| 120 | MP0000579_abnormal_nail_morphology | 1.01485191 |
| 121 | MP0002928_abnormal_bile_duct | 0.99781968 |
| 122 | MP0005220_abnormal_exocrine_pancreas | 0.98056266 |
| 123 | MP0002060_abnormal_skin_morphology | 0.96816114 |
| 124 | MP0002163_abnormal_gland_morphology | 0.94609055 |
| 125 | MP0000566_synostosis | 0.92928416 |
| 126 | MP0002254_reproductive_system_inflammat | 0.90971440 |
| 127 | MP0008961_abnormal_basal_metabolism | 0.90786537 |
| 128 | MP0010234_abnormal_vibrissa_follicle | 0.89249584 |
| 129 | MP0001944_abnormal_pancreas_morphology | 0.88272481 |
| 130 | MP0002295_abnormal_pulmonary_circulatio | 0.88181642 |
| 131 | MP0001986_abnormal_taste_sensitivity | 0.87790600 |
| 132 | MP0002229_neurodegeneration | 0.86515109 |
| 133 | MP0003937_abnormal_limbs/digits/tail_de | 0.86360565 |
| 134 | MP0009115_abnormal_fat_cell | 0.85531802 |
| 135 | MP0000598_abnormal_liver_morphology | 0.85323191 |
| 136 | MP0000778_abnormal_nervous_system | 0.85003111 |
| 137 | MP0004858_abnormal_nervous_system | 0.83733419 |
| 138 | MP0000462_abnormal_digestive_system | 0.83373035 |
| 139 | MP0005410_abnormal_fertilization | 0.83314420 |
| 140 | MP0005452_abnormal_adipose_tissue | 0.82688217 |
| 141 | MP0001881_abnormal_mammary_gland | 0.82444144 |
| 142 | MP0003122_maternal_imprinting | 0.80920596 |
| 143 | MP0003300_gastrointestinal_ulcer | 0.79914070 |
| 144 | MP0002909_abnormal_adrenal_gland | 0.79304639 |
| 145 | MP0002822_catalepsy | 0.78654952 |
| 146 | MP0003137_abnormal_impulse_conducting | 0.78129778 |
| 147 | MP0000955_abnormal_spinal_cord | 0.77805574 |
| 148 | MP0008260_abnormal_autophagy | 0.77554983 |
| 149 | MP0003698_abnormal_male_reproductive | 0.77529309 |
| 150 | MP0005195_abnormal_posterior_eye | 0.77278084 |
| 151 | MP0003011_delayed_dark_adaptation | 0.76394373 |
| 152 | MP0003953_abnormal_hormone_level | 0.75929847 |
| 153 | MP0003656_abnormal_erythrocyte_physiolo | 0.75746163 |
| 154 | MP0009642_abnormal_blood_homeostasis | 0.74877084 |
| 155 | MP0003634_abnormal_glial_cell | 0.73849710 |
| 156 | MP0002168_other_aberrant_phenotype | 0.72900125 |
| 157 | MP0004270_analgesia | 0.71493468 |
| 158 | MP0001243_abnormal_dermal_layer | 0.70570283 |
| 159 | MP0001958_emphysema | 0.69257146 |
| 160 | MP0009672_abnormal_birth_weight | 0.68637148 |
| 161 | MP0006036_abnormal_mitochondrial_physio | 0.68252536 |
| 162 | MP0001765_abnormal_ion_homeostasis | 0.66444002 |
| 163 | MP0002136_abnormal_kidney_physiology | 0.66025995 |
| 164 | MP0005084_abnormal_gallbladder_morpholo | 0.64655866 |
| 165 | MP0002896_abnormal_bone_mineralization | 0.63959606 |
| 166 | MP0005395_other_phenotype | 0.63500946 |
| 167 | MP0000647_abnormal_sebaceous_gland | 0.61755071 |
| 168 | MP0005408_hypopigmentation | 0.60962788 |
| 169 | MP0002877_abnormal_melanocyte_morpholog | 0.59716299 |
| 170 | MP0000538_abnormal_urinary_bladder | 0.59070677 |
| 171 | MP0004272_abnormal_basement_membrane | 0.58389271 |
| 172 | MP0003633_abnormal_nervous_system | 0.57725861 |
| 173 | MP0001542_abnormal_bone_strength | 0.57226533 |
| 174 | MP0002069_abnormal_eating/drinking_beha | 0.54030622 |
| 175 | MP0005501_abnormal_skin_physiology | 0.53807500 |
| 176 | MP0000747_muscle_weakness | 0.53805219 |
| 177 | MP0001177_atelectasis | 0.51619525 |
| 178 | MP0000230_abnormal_systemic_arterial | 0.51342554 |
| 179 | MP0002733_abnormal_thermal_nociception | 0.51128796 |
| 180 | MP0009763_increased_sensitivity_to | 0.51064324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Xanthomatosis (HP:0000991) | 5.19168161 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.09821550 |
| 3 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.48174159 |
| 4 | Abnormality of glycine metabolism (HP:0010895) | 4.48174159 |
| 5 | Hyperglycinuria (HP:0003108) | 4.38494670 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.19064470 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 4.18304698 |
| 8 | Hyperglycinemia (HP:0002154) | 4.07002724 |
| 9 | Ketosis (HP:0001946) | 4.03237772 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.02465351 |
| 11 | Ketoacidosis (HP:0001993) | 3.86278789 |
| 12 | Pancreatic cysts (HP:0001737) | 3.83643937 |
| 13 | Epidermoid cyst (HP:0200040) | 3.80669964 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.79053545 |
| 15 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.63419642 |
| 16 | Neurofibrillary tangles (HP:0002185) | 3.60301429 |
| 17 | Genetic anticipation (HP:0003743) | 3.47583275 |
| 18 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.42719547 |
| 19 | Large for gestational age (HP:0001520) | 3.41193863 |
| 20 | Molar tooth sign on MRI (HP:0002419) | 3.40762864 |
| 21 | Abnormality of midbrain morphology (HP:0002418) | 3.40762864 |
| 22 | Hyperventilation (HP:0002883) | 3.36591181 |
| 23 | Hypobetalipoproteinemia (HP:0003563) | 3.29949622 |
| 24 | Cerebral inclusion bodies (HP:0100314) | 3.28537743 |
| 25 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.27354292 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 3.26911456 |
| 27 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.24387079 |
| 28 | Abnormality of alanine metabolism (HP:0010916) | 3.24387079 |
| 29 | Hyperalaninemia (HP:0003348) | 3.24387079 |
| 30 | Hyperammonemia (HP:0001987) | 3.23357702 |
| 31 | Pancreatic fibrosis (HP:0100732) | 3.23183377 |
| 32 | Congenital stationary night blindness (HP:0007642) | 3.21664452 |
| 33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.19862951 |
| 34 | True hermaphroditism (HP:0010459) | 3.17662677 |
| 35 | Type II lissencephaly (HP:0007260) | 3.16051426 |
| 36 | Tubular atrophy (HP:0000092) | 3.07918433 |
| 37 | Inability to walk (HP:0002540) | 3.06638011 |
| 38 | Nephronophthisis (HP:0000090) | 3.04184720 |
| 39 | Abnormality of the renal cortex (HP:0011035) | 3.02912843 |
| 40 | Protruding tongue (HP:0010808) | 3.01209674 |
| 41 | Cerebellar dysplasia (HP:0007033) | 2.99090506 |
| 42 | Complement deficiency (HP:0004431) | 2.97038809 |
| 43 | Gout (HP:0001997) | 2.90518441 |
| 44 | Progressive cerebellar ataxia (HP:0002073) | 2.82322924 |
| 45 | Hypoglycemic seizures (HP:0002173) | 2.78196901 |
| 46 | Cystic liver disease (HP:0006706) | 2.77936058 |
| 47 | Prolonged partial thromboplastin time (HP:0003645) | 2.76358259 |
| 48 | Attenuation of retinal blood vessels (HP:0007843) | 2.74770496 |
| 49 | Premature rupture of membranes (HP:0001788) | 2.74568346 |
| 50 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.71258206 |
| 51 | Abnormality of the renal medulla (HP:0100957) | 2.70935659 |
| 52 | Clumsiness (HP:0002312) | 2.70478579 |
| 53 | Abnormality of glycolysis (HP:0004366) | 2.69683818 |
| 54 | Increased serum pyruvate (HP:0003542) | 2.69683818 |
| 55 | Hypolipoproteinemia (HP:0010981) | 2.68559904 |
| 56 | Abnormality of purine metabolism (HP:0004352) | 2.65437899 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.64171356 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62827910 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.62827910 |
| 60 | Progressive inability to walk (HP:0002505) | 2.62327353 |
| 61 | Hypoplasia of the pons (HP:0012110) | 2.61693435 |
| 62 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.60516077 |
| 63 | Patellar aplasia (HP:0006443) | 2.60167831 |
| 64 | Hyperglycemia (HP:0003074) | 2.59329240 |
| 65 | Abnormality of the pons (HP:0007361) | 2.59144184 |
| 66 | Skin nodule (HP:0200036) | 2.59071805 |
| 67 | Irritability (HP:0000737) | 2.55763463 |
| 68 | Concave nail (HP:0001598) | 2.53444026 |
| 69 | Hypoalphalipoproteinemia (HP:0003233) | 2.51322033 |
| 70 | Birth length less than 3rd percentile (HP:0003561) | 2.49495194 |
| 71 | Duplicated collecting system (HP:0000081) | 2.48192680 |
| 72 | Severe muscular hypotonia (HP:0006829) | 2.46345137 |
| 73 | Brushfield spots (HP:0001088) | 2.44762609 |
| 74 | Abnormal cartilage morphology (HP:0002763) | 2.44205054 |
| 75 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.43713305 |
| 76 | Abnormality of serum amino acid levels (HP:0003112) | 2.43146747 |
| 77 | Broad-based gait (HP:0002136) | 2.42989313 |
| 78 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.39242755 |
| 79 | Generalized aminoaciduria (HP:0002909) | 2.38472070 |
| 80 | Furrowed tongue (HP:0000221) | 2.37826627 |
| 81 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.34860760 |
| 82 | Decreased circulating renin level (HP:0003351) | 2.34159752 |
| 83 | Abnormality of the renal collecting system (HP:0004742) | 2.29753579 |
| 84 | Chronic hepatic failure (HP:0100626) | 2.29720655 |
| 85 | Late onset (HP:0003584) | 2.28801664 |
| 86 | Febrile seizures (HP:0002373) | 2.28665176 |
| 87 | Epiphyseal stippling (HP:0010655) | 2.27620892 |
| 88 | Termporal pattern (HP:0011008) | 2.25316265 |
| 89 | Insidious onset (HP:0003587) | 2.25316265 |
| 90 | Amelogenesis imperfecta (HP:0000705) | 2.24711022 |
| 91 | Pendular nystagmus (HP:0012043) | 2.24422228 |
| 92 | Abnormality of methionine metabolism (HP:0010901) | 2.23362716 |
| 93 | Abnormality of the common coagulation pathway (HP:0010990) | 2.23268268 |
| 94 | Myocardial infarction (HP:0001658) | 2.22829035 |
| 95 | Hydroxyprolinuria (HP:0003080) | 2.22785014 |
| 96 | Abnormality of proline metabolism (HP:0010907) | 2.22785014 |
| 97 | Lissencephaly (HP:0001339) | 2.21663451 |
| 98 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.21366012 |
| 99 | Turricephaly (HP:0000262) | 2.21133119 |
| 100 | Fat malabsorption (HP:0002630) | 2.19364589 |
| 101 | Abnormality of nucleobase metabolism (HP:0010932) | 2.15337975 |
| 102 | Abnormality of complement system (HP:0005339) | 2.14874426 |
| 103 | Lethargy (HP:0001254) | 2.14338077 |
| 104 | Supranuclear gaze palsy (HP:0000605) | 2.14310206 |
| 105 | Stridor (HP:0010307) | 2.13463776 |
| 106 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13381398 |
| 107 | Hypercholesterolemia (HP:0003124) | 2.11289749 |
| 108 | Polydipsia (HP:0001959) | 2.10010035 |
| 109 | Abnormal drinking behavior (HP:0030082) | 2.10010035 |
| 110 | Congenital, generalized hypertrichosis (HP:0004540) | 2.07456021 |
| 111 | Cerebral hemorrhage (HP:0001342) | 2.06643291 |
| 112 | Medial flaring of the eyebrow (HP:0010747) | 2.04859195 |
| 113 | Hemiparesis (HP:0001269) | 2.04748977 |
| 114 | Insulin resistance (HP:0000855) | 2.03798294 |
| 115 | Sclerocornea (HP:0000647) | 2.03580605 |
| 116 | Symptomatic seizures (HP:0011145) | 2.02553563 |
| 117 | Conjugated hyperbilirubinemia (HP:0002908) | 2.02051225 |
| 118 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.01972767 |
| 119 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.00599436 |
| 120 | Protuberant abdomen (HP:0001538) | 1.99672320 |
| 121 | Oligomenorrhea (HP:0000876) | 1.99491960 |
| 122 | Focal seizures (HP:0007359) | 1.99004982 |
| 123 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.98236091 |
| 124 | Metabolic acidosis (HP:0001942) | 1.97944032 |
| 125 | Hypsarrhythmia (HP:0002521) | 1.97695064 |
| 126 | Opisthotonus (HP:0002179) | 1.96913129 |
| 127 | Increased purine levels (HP:0004368) | 1.96281948 |
| 128 | Hyperuricemia (HP:0002149) | 1.96281948 |
| 129 | Epileptiform EEG discharges (HP:0011182) | 1.95751427 |
| 130 | Peritonitis (HP:0002586) | 1.95405469 |
| 131 | Abnormal gallbladder morphology (HP:0012437) | 1.95258345 |
| 132 | EEG with generalized epileptiform discharges (HP:0011198) | 1.95224335 |
| 133 | Hand muscle atrophy (HP:0009130) | 1.95131071 |
| 134 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92549527 |
| 135 | Delayed CNS myelination (HP:0002188) | 1.92207290 |
| 136 | Abolished electroretinogram (ERG) (HP:0000550) | 1.91923733 |
| 137 | Abnormality of the corticospinal tract (HP:0002492) | 1.91837734 |
| 138 | Fair hair (HP:0002286) | 1.91823038 |
| 139 | Pancreatitis (HP:0001733) | 1.90636377 |
| 140 | Abnormal tarsal ossification (HP:0008369) | 1.89713713 |
| 141 | Axonal loss (HP:0003447) | 1.86137062 |
| 142 | Partial agenesis of the corpus callosum (HP:0001338) | 1.84319550 |
| 143 | Hyperbilirubinemia (HP:0002904) | 1.84118811 |
| 144 | Proximal tubulopathy (HP:0000114) | 1.83458815 |
| 145 | Methylmalonic aciduria (HP:0012120) | 1.83204912 |
| 146 | Pheochromocytoma (HP:0002666) | 1.82985012 |
| 147 | Renal cortical cysts (HP:0000803) | 1.82879089 |
| 148 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.82623941 |
| 149 | Tachypnea (HP:0002789) | 1.82450305 |
| 150 | Chorioretinal atrophy (HP:0000533) | 1.81617766 |
| 151 | Elevated alkaline phosphatase (HP:0003155) | 1.81239384 |
| 152 | Acanthosis nigricans (HP:0000956) | 1.81234347 |
| 153 | Abnormal epiphyseal ossification (HP:0010656) | 1.80858433 |
| 154 | Glycosuria (HP:0003076) | 1.80772313 |
| 155 | Abnormality of urine glucose concentration (HP:0011016) | 1.80772313 |
| 156 | Hypertriglyceridemia (HP:0002155) | 1.80188443 |
| 157 | Impaired smooth pursuit (HP:0007772) | 1.79894082 |
| 158 | Cholecystitis (HP:0001082) | 1.78878985 |
| 159 | Abnormal gallbladder physiology (HP:0012438) | 1.78878985 |
| 160 | Absent speech (HP:0001344) | 1.78869051 |
| 161 | Vomiting (HP:0002013) | 1.78291865 |
| 162 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78129962 |
| 163 | Keratoconus (HP:0000563) | 1.77382718 |
| 164 | Increased corneal curvature (HP:0100692) | 1.77382718 |
| 165 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.77267482 |
| 166 | Ileus (HP:0002595) | 1.76449200 |
| 167 | Upper limb amyotrophy (HP:0009129) | 1.75890891 |
| 168 | Distal upper limb amyotrophy (HP:0007149) | 1.75890891 |
| 169 | Bronchomalacia (HP:0002780) | 1.75808283 |
| 170 | Widely spaced teeth (HP:0000687) | 1.75743802 |
| 171 | Pachygyria (HP:0001302) | 1.74518877 |
| 172 | Bile duct proliferation (HP:0001408) | 1.73999897 |
| 173 | Abnormal biliary tract physiology (HP:0012439) | 1.73999897 |
| 174 | Epileptic encephalopathy (HP:0200134) | 1.73793058 |
| 175 | Drooling (HP:0002307) | 1.72058883 |
| 176 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.69327410 |
| 177 | Gait imbalance (HP:0002141) | 1.69101400 |
| 178 | Dialeptic seizures (HP:0011146) | 1.68767789 |
| 179 | Bulbous nose (HP:0000414) | 1.65634417 |
| 180 | Abnormality of the carotid arteries (HP:0005344) | 1.63688407 |
| 181 | Congenital hepatic fibrosis (HP:0002612) | 1.63339286 |
| 182 | Hypothermia (HP:0002045) | 1.63305825 |
| 183 | Bilateral microphthalmos (HP:0007633) | 1.62751897 |
| 184 | Hypoplastic labia majora (HP:0000059) | 1.62644697 |
| 185 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.62608101 |
| 186 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.62582815 |
| 187 | Agitation (HP:0000713) | 1.62063096 |
| 188 | Hypoplastic ischia (HP:0003175) | 1.60867248 |
| 189 | Male pseudohermaphroditism (HP:0000037) | 1.57710685 |
| 190 | Oligodontia (HP:0000677) | 1.57480900 |
| 191 | Polyuria (HP:0000103) | 1.56477208 |
| 192 | Hypoalbuminemia (HP:0003073) | 1.55615801 |
| 193 | Abnormal albumin level (HP:0012116) | 1.55615801 |
| 194 | Dandy-Walker malformation (HP:0001305) | 1.55393475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 3.89848007 |
| 2 | TRIB3 | 3.75319355 |
| 3 | BCKDK | 3.72906104 |
| 4 | SIK1 | 3.64720805 |
| 5 | EPHB1 | 3.40357140 |
| 6 | BMPR1B | 3.28088029 |
| 7 | ACVR1B | 3.16011046 |
| 8 | TLK1 | 3.15224136 |
| 9 | ADRBK2 | 2.99061212 |
| 10 | ERN1 | 2.95622416 |
| 11 | CAMK1D | 2.69312082 |
| 12 | EEF2K | 2.65536584 |
| 13 | CAMK1G | 2.24427689 |
| 14 | STK39 | 2.18444926 |
| 15 | WNK4 | 2.18334123 |
| 16 | MET | 2.14906660 |
| 17 | NTRK1 | 2.13491774 |
| 18 | CASK | 2.00868757 |
| 19 | TNIK | 1.98493464 |
| 20 | INSRR | 1.96603638 |
| 21 | FGFR4 | 1.96017637 |
| 22 | GRK1 | 1.94352513 |
| 23 | MST1R | 1.88770652 |
| 24 | MARK1 | 1.88363613 |
| 25 | MAP3K2 | 1.78823507 |
| 26 | MAPKAPK3 | 1.74092203 |
| 27 | MAP3K4 | 1.72149687 |
| 28 | OXSR1 | 1.66095896 |
| 29 | MAPKAPK5 | 1.64745308 |
| 30 | DYRK2 | 1.53006125 |
| 31 | PKN2 | 1.48059156 |
| 32 | TESK2 | 1.47638032 |
| 33 | LIMK1 | 1.45167209 |
| 34 | NTRK3 | 1.43175434 |
| 35 | PAK3 | 1.33131735 |
| 36 | WNK3 | 1.29271948 |
| 37 | NUAK1 | 1.28237061 |
| 38 | TGFBR1 | 1.26654876 |
| 39 | MAP2K7 | 1.25603443 |
| 40 | FRK | 1.23501645 |
| 41 | ADRBK1 | 1.22235496 |
| 42 | EPHA3 | 1.21349554 |
| 43 | PINK1 | 1.21082042 |
| 44 | MAP2K1 | 1.20102561 |
| 45 | ARAF | 1.19636996 |
| 46 | MKNK2 | 1.19582902 |
| 47 | PTK2 | 1.18705201 |
| 48 | CSNK1G3 | 1.18454639 |
| 49 | MAP2K6 | 1.09682594 |
| 50 | FGFR2 | 1.08990986 |
| 51 | PNCK | 1.08605984 |
| 52 | MAP4K2 | 1.07958262 |
| 53 | LATS2 | 1.05647016 |
| 54 | STK38L | 1.05609563 |
| 55 | DAPK2 | 1.05113845 |
| 56 | CSNK1A1L | 1.04766634 |
| 57 | KSR2 | 1.04219326 |
| 58 | MAPK15 | 1.04095229 |
| 59 | PRKD3 | 1.01826729 |
| 60 | RIPK1 | 1.01144904 |
| 61 | BCR | 1.00539810 |
| 62 | DDR2 | 1.00366946 |
| 63 | ERBB4 | 1.00040265 |
| 64 | RET | 0.98473498 |
| 65 | EPHA4 | 0.96777780 |
| 66 | PDK4 | 0.95525133 |
| 67 | PDK3 | 0.95525133 |
| 68 | CSNK1G2 | 0.94656503 |
| 69 | LMTK2 | 0.94246832 |
| 70 | CSNK1G1 | 0.93786786 |
| 71 | MAP3K3 | 0.93028075 |
| 72 | MAP2K2 | 0.92633513 |
| 73 | AKT3 | 0.90980554 |
| 74 | PAK6 | 0.88548208 |
| 75 | TAOK3 | 0.88032490 |
| 76 | PRKCG | 0.86895327 |
| 77 | FER | 0.86476567 |
| 78 | SIK2 | 0.86281844 |
| 79 | PRKCE | 0.81472532 |
| 80 | PDPK1 | 0.80124199 |
| 81 | GSK3A | 0.79458082 |
| 82 | MAPK11 | 0.76671150 |
| 83 | PIK3CA | 0.75506612 |
| 84 | CAMK1 | 0.73496904 |
| 85 | SGK223 | 0.72792504 |
| 86 | SGK494 | 0.72792504 |
| 87 | PDGFRA | 0.71866252 |
| 88 | TXK | 0.71046890 |
| 89 | PRKAA2 | 0.69058127 |
| 90 | TESK1 | 0.68249800 |
| 91 | ABL2 | 0.67760207 |
| 92 | MTOR | 0.67711968 |
| 93 | SCYL2 | 0.66538904 |
| 94 | PTK6 | 0.66278104 |
| 95 | PKN1 | 0.65436099 |
| 96 | MUSK | 0.64883142 |
| 97 | PRKAA1 | 0.64184988 |
| 98 | NEK2 | 0.63235759 |
| 99 | NLK | 0.62327591 |
| 100 | VRK1 | 0.61955199 |
| 101 | FLT3 | 0.61236198 |
| 102 | PRKCH | 0.60985903 |
| 103 | PIK3CG | 0.58885951 |
| 104 | TRPM7 | 0.58340444 |
| 105 | RPS6KA5 | 0.58245065 |
| 106 | PHKG2 | 0.58159254 |
| 107 | PHKG1 | 0.58159254 |
| 108 | PRKCZ | 0.57031512 |
| 109 | BRSK2 | 0.55619052 |
| 110 | MAP3K9 | 0.55396829 |
| 111 | CAMKK2 | 0.53471777 |
| 112 | MARK2 | 0.52657282 |
| 113 | RPS6KB2 | 0.49610304 |
| 114 | UHMK1 | 0.49053201 |
| 115 | NME1 | 0.48784246 |
| 116 | PIM2 | 0.48658786 |
| 117 | PASK | 0.48179200 |
| 118 | PRKACG | 0.48169585 |
| 119 | CSK | 0.47024075 |
| 120 | CHUK | 0.46973004 |
| 121 | STK11 | 0.46950221 |
| 122 | CAMKK1 | 0.46825664 |
| 123 | MAPK12 | 0.45554612 |
| 124 | MAPK13 | 0.44839750 |
| 125 | ICK | 0.44767144 |
| 126 | RPS6KA2 | 0.44378963 |
| 127 | LRRK2 | 0.42426845 |
| 128 | SGK2 | 0.42056589 |
| 129 | CDK14 | 0.41324799 |
| 130 | TYRO3 | 0.41306469 |
| 131 | PRKD1 | 0.40214950 |
| 132 | PBK | 0.39594172 |
| 133 | MAP2K4 | 0.39525020 |
| 134 | PDK1 | 0.39027734 |
| 135 | CHEK2 | 0.38969762 |
| 136 | DYRK1B | 0.38229302 |
| 137 | CDK5 | 0.37642904 |
| 138 | CAMK2A | 0.37263940 |
| 139 | CSNK1A1 | 0.37198285 |
| 140 | IRAK1 | 0.37189987 |
| 141 | EPHA2 | 0.35877046 |
| 142 | PTK2B | 0.34327632 |
| 143 | PAK2 | 0.33453869 |
| 144 | MELK | 0.32444443 |
| 145 | PRKCI | 0.31844414 |
| 146 | MAPK4 | 0.31093825 |
| 147 | PDK2 | 0.30543416 |
| 148 | RPS6KA6 | 0.30242267 |
| 149 | JAK1 | 0.29929805 |
| 150 | CSNK1D | 0.27770857 |
| 151 | ATR | 0.26815880 |
| 152 | PLK1 | 0.26194328 |
| 153 | ERBB2 | 0.26022322 |
| 154 | PLK2 | 0.25566081 |
| 155 | PRKACA | 0.25379071 |
| 156 | NTRK2 | 0.25156615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.36459332 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.23371289 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.11608468 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.05651376 |
| 5 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.92026003 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.67022177 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66669161 |
| 8 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.64479558 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.63295013 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.60885384 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.48263163 |
| 12 | Phototransduction_Homo sapiens_hsa04744 | 2.40848125 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39785863 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 2.38918142 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.36310895 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.29819661 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.28996410 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26077982 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.20893902 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.20363985 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.18123751 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.99824791 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.96454515 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.88519238 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.87189569 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.80874486 |
| 27 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.74188968 |
| 28 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.69620515 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.68491032 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.68182472 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.64718477 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.64053995 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.62103982 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.61790707 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.60717271 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.56771474 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.55079610 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53132490 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.48839065 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.45538821 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42829104 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31059075 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30898523 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.30715037 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29457797 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28437524 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.27829006 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27662411 |
| 49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.26138625 |
| 50 | Circadian entrainment_Homo sapiens_hsa04713 | 1.25775911 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.25339861 |
| 52 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.24302384 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22575406 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.22212292 |
| 55 | RNA polymerase_Homo sapiens_hsa03020 | 1.19732254 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17686778 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16844244 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16492620 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15137178 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 1.12476489 |
| 61 | Olfactory transduction_Homo sapiens_hsa04740 | 1.11739706 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 1.10501271 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.09351022 |
| 64 | GABAergic synapse_Homo sapiens_hsa04727 | 1.06420040 |
| 65 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.05441386 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01983544 |
| 67 | Salivary secretion_Homo sapiens_hsa04970 | 1.01220034 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00613144 |
| 69 | Retinol metabolism_Homo sapiens_hsa00830 | 1.00554901 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.99422128 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.97890849 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97036668 |
| 73 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.96550333 |
| 74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.95044305 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93424175 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92912465 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89466659 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88971523 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.88225079 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87882572 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82716590 |
| 82 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.82194707 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80344335 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79491437 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78178280 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76101173 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75641220 |
| 88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73448744 |
| 89 | Basal transcription factors_Homo sapiens_hsa03022 | 0.70124959 |
| 90 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68409610 |
| 91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.67632169 |
| 92 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67130344 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65912078 |
| 94 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.64986977 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.62455857 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61705112 |
| 97 | Long-term depression_Homo sapiens_hsa04730 | 0.59669839 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.58241569 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57872107 |
| 100 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57575914 |
| 101 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.57530014 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57486383 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54712644 |
| 104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54613554 |
| 105 | Purine metabolism_Homo sapiens_hsa00230 | 0.54047195 |
| 106 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53837987 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53600970 |
| 108 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52630085 |
| 109 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52457740 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52372090 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49529034 |
| 112 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47941558 |
| 113 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46812748 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46715372 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45564795 |
| 116 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44401732 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.43962714 |
| 118 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42937752 |
| 119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42781638 |
| 120 | Protein export_Homo sapiens_hsa03060 | 0.41886993 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40124109 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.39225907 |
| 123 | Lysosome_Homo sapiens_hsa04142 | 0.36948136 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.35971645 |
| 125 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33678603 |
| 126 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33166093 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28671864 |
| 128 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25140576 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24667227 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23859787 |
| 131 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.21940873 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17231976 |
| 133 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.16713324 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14404977 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12131527 |
| 136 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.11928484 |
| 137 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.11123319 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.06579126 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05368539 |
| 140 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.04928024 |
| 141 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.04912058 |
| 142 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03259677 |
| 143 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.02634171 |
| 144 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.01285710 |
| 145 | Phagosome_Homo sapiens_hsa04145 | 0.00149769 |
| 146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0028572 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0026395 |

